These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
319 related items for PubMed ID: 33234920
1. Comparative Performance of 99mTc-TRODAT-1 SPECT/CT and 18F-FDOPA PET/CT Imaging in Patients With Parkinson's Disease, Parkinson-Plus Syndrome, and Essential Tremor. Sood A, Shukla J, Shree R, Vatsa R, Modi M, Mittal BR. Clin Nucl Med; 2021 Feb 01; 46(2):95-102. PubMed ID: 33234920 [Abstract] [Full Text] [Related]
2. 99mTc-TRODAT-1 SPECT/CT imaging as a complementary biomarker in the diagnosis of parkinsonian syndromes. Mittal BR, Sood A, Shukla J, Vatsa R, Bhusari P, Shree R, Mehta S, Goyal M, Modi M. Nucl Med Commun; 2018 Apr 01; 39(4):312-318. PubMed ID: 29381583 [Abstract] [Full Text] [Related]
5. Comparison of 99mTc-TRODAT-1 SPECT and 18 F-AV-133 PET imaging in healthy controls and Parkinson's disease patients. Hsiao IT, Weng YH, Lin WY, Hsieh CJ, Wey SP, Yen TC, Kung MP, Lu CS, Lin KJ. Nucl Med Biol; 2014 Apr 01; 41(4):322-9. PubMed ID: 24503330 [Abstract] [Full Text] [Related]
6. 99mTc-TRODAT-1 SPECT study in early Parkinson's disease and essential tremor. Wang J, Jiang YP, Liu XD, Chen ZP, Yang LQ, Liu CJ, Xiang JD, Su HL. Acta Neurol Scand; 2005 Dec 01; 112(6):380-5. PubMed ID: 16281920 [Abstract] [Full Text] [Related]
7. [Imaging of dopamine transporter with Tc99m-Trodat-SPECT in movement disorders]. Kanyó B, Argyelán M, Dibó G, Szakonyi Z, Vécsei L, Fülöp F, Láncz A, Forgács P, Pávics L. Ideggyogy Sz; 2003 Jul 20; 56(7-8):231-40. PubMed ID: 12971118 [Abstract] [Full Text] [Related]
8. Investigating the role of 99mTc-TRODAT-1 SPECT imaging in idiopathic Parkinson's disease. Geng Y, Shi GH, Jiang Y, Xu LX, Hu XY, Shao YQ. J Zhejiang Univ Sci B; 2005 Jan 20; 6(1):22-7. PubMed ID: 15593387 [Abstract] [Full Text] [Related]
9. A phase 2, open-label, multi-center study to evaluate the efficacy and safety of 99mTc-TRODAT-1 SPECT to detect Parkinson's disease. Sun Y, Liu C, Chen Z, Li B, Lv Z, Lou J, Tang J, Wang Y, Zhang G, Liu X. Ann Nucl Med; 2020 Jan 20; 34(1):31-37. PubMed ID: 31646428 [Abstract] [Full Text] [Related]
14. Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease. Thobois S, Guillouet S, Broussolle E. Neurophysiol Clin; 2001 Oct 20; 31(5):321-40. PubMed ID: 11817273 [Abstract] [Full Text] [Related]
15. Sensitivity and specificity of 99mTc-TRODAT-1 SPECT imaging in differentiating patients with idiopathic Parkinson's disease from healthy subjects. Weng YH, Yen TC, Chen MC, Kao PF, Tzen KY, Chen RS, Wey SP, Ting G, Lu CS. J Nucl Med; 2004 Mar 20; 45(3):393-401. PubMed ID: 15001678 [Abstract] [Full Text] [Related]
16. Comparison of perfusion 18F-FP-CIT PET and 99mTc-ECD SPECT in parkinsonian disorders. Chun K, Kong E, Cho I. Medicine (Baltimore); 2021 Aug 27; 100(34):e27019. PubMed ID: 34449475 [Abstract] [Full Text] [Related]
17. Brain TRODAT-SPECT Versus MRI Morphometry in Distinguishing Early Mild Parkinson's Disease from Other Extrapyramidal Syndromes. Hossein-Tehrani MR, Ghaedian T, Hooshmandi E, Kalhor L, Foroughi AA, Ostovan VR. J Neuroimaging; 2020 Sep 27; 30(5):683-689. PubMed ID: 32557946 [Abstract] [Full Text] [Related]
18. Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET. Ishikawa T, Dhawan V, Kazumata K, Chaly T, Mandel F, Neumeyer J, Margouleff C, Babchyck B, Zanzi I, Eidelberg D. J Nucl Med; 1996 Nov 27; 37(11):1760-5. PubMed ID: 8917170 [Abstract] [Full Text] [Related]